For the past eight years, GSK had been working toward the creation of an independent healthcare company, according to a Feb. 22 press release. Now, with the development of Haleon, that ambition is becoming a reality.
Six things to know about Haleon:
1. In June 2021, GSK announced its intent to demerge its consumer health unit from its pharmaceutical business.
2. Brands that will fall under Haleon will include Sensodyne toothpaste, Voltaren arthritis cream, Advil, Panadol, Excedrin, Centrum multivitamin, Tums, ChapStick, Nicorette and Nexium, according to Forbes.
3. The company will be deployed in 100 markets around the world.
4. Haleon is on track to be launched in mid-2022.
5. Haleon’s brand identity was developed with employees, healthcare practitioners and consumers.
6. Haleon will also have a new logo, stepping away from GSK’s bright orange and embracing a black and green style, Forbes reported.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
